65 I B, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79721D0183
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 96% complete
IDV ceiling
$40,190,500.00
Award type
Multiple award
Who can order
All agencies
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

VA's Veterans Integrated Service Network 12 awarded a Federal Supply Schedule contract to Akebia Therapeutics, Inc. under the Pharmaceuticals and Drugs schedule (FSS-61-IB) effective July 1, 2021, with a contract ceiling of $40,190,500 and performance through January 31, 2027. The contract covers drugs, pharmaceuticals, and hematology-related products under a short-term contract extension vehicle. A single-award Blanket Purchase Agreement issued April 25, 2025 under this Schedule contract carries a ceiling of $10,254,764.65 and covers Vafsxeo and Auryxia products, with Option Year 1 exercised and performance extending through April 24, 2027. The BPA represents active ordering activity and agency utilization of the Schedule vehicle for pharmaceutical procurement.

IDV awards

IDV Agency Ceiling Awarded
36E79725A0015 New BPA for vafseo and auryxia National Acquisition Center (VA) $10,254,765

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00016 · 65IB short term contract extension $0
Supplemental Agreement for work within scope P00015 · 2026 public law pricing updates $0
Supplemental Agreement for work within scope P00014 · Lifecycle change from temporary to permanent $0
Supplemental Agreement for work within scope P00012 · 65IB 42-2A permanent price decrease (PPR) big 4 only - nfamp restatement $0
Supplemental Agreement for work within scope P00013 · 65IB admin change - ordering terms to specialty distribution $0
Supplemental Agreement for work within scope P00011 · 42-2A product addition $0
Other Administrative Action P00010 · Admin changes - points of contact $0
Supplemental Agreement for work within scope P00009 · 65IB 2025 public law pricing updates $0
Supplemental Agreement for work within scope P00008 · 65IB - admin change company phone and RGP $0
Other Administrative Action P00007 · Administrative changes - points of contact and signatory authority form updates $0
Supplemental Agreement for work within scope P00006 · 65IB 42-2A tracking customer change $0
Supplemental Agreement for work within scope P00005 · 2024 public law pricing updates $0
Other Administrative Action P00004 · 65IB administrative change to signatory authority form $0
Supplemental Agreement for work within scope P00003 · 2023 public law pricing updates $0
Supplemental Agreement for work within scope P00002 · 65IB 42-2A permanent price reduction $0
Supplemental Agreement for work within scope P00001 · 2022 public law pricing updates $0
Original award $0
Show all 17

Quick answers

Who was awarded contract 36F79721D0183?

36F79721D0183 was awarded to Akebia Therapeutics, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on July 1, 2021.

How much is contract 36F79721D0183 worth?

36F79721D0183's own ceiling is $40,190,500.

Who can order from contract 36F79721D0183?

36F79721D0183 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79721D0183 part of a contract vehicle?

Yes. 36F79721D0183 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79721D0183 competed?

The extent of competition for 36F79721D0183 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV